LYRA
Price
$0.18
Change
+$0.01 (+5.88%)
Updated
Dec 20 closing price
72 days until earnings call
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Dec 20 closing price
88 days until earnings call
Ad is loading...

LYRA vs SQZB

Header iconLYRA vs SQZB Comparison
Open Charts LYRA vs SQZBBanner chart's image
Lyra Therapeutics
Price$0.18
Change+$0.01 (+5.88%)
Volume$2.25M
CapitalizationN/A
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$6.9K
CapitalizationN/A
LYRA vs SQZB Comparison Chart
Loading...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYRA vs. SQZB commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRA is a Hold and SQZB is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (LYRA: $0.18 vs. SQZB: $0.03)
Brand notoriety: LYRA and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYRA: 109% vs. SQZB: 47%
Market capitalization -- LYRA: $11.78M vs. SQZB: $737.28K
LYRA [@Biotechnology] is valued at $11.78M. SQZB’s [@Biotechnology] market capitalization is $737.28K. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYRA’s FA Score shows that 1 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • LYRA’s FA Score: 1 green, 4 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, both LYRA and SQZB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYRA’s TA Score shows that 4 TA indicator(s) are bullish while SQZB’s TA Score has 4 bullish TA indicator(s).

  • LYRA’s TA Score: 4 bullish, 5 bearish.
  • SQZB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SQZB is a better buy in the short-term than LYRA.

Price Growth

LYRA (@Biotechnology) experienced а -1.42% price change this week, while SQZB (@Biotechnology) price change was -9.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

LYRA is expected to report earnings on Mar 05, 2025.

SQZB is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LYRA($11.8M) has a higher market cap than SQZB($737K). SQZB YTD gains are higher at: 25.628 vs. LYRA (-96.565).
LYRASQZBLYRA / SQZB
Capitalization11.8M737K1,601%
EBITDA-67.04MN/A-
Gain YTD-96.56525.628-377%
P/E RatioN/AN/A-
Revenue1.47MN/A-
Total Cash51.6MN/A-
Total Debt35.3MN/A-
TECHNICAL ANALYSIS
Technical Analysis
LYRASQZB
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 21 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 6 days ago
88%
View a ticker or compare two or three
Ad is loading...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COF178.652.99
+1.70%
Capital One Financial
BRFS4.350.07
+1.64%
BRF - Brasil Foods SA
FCF16.930.14
+0.83%
First Commonwealth Financial Corp
APYX1.570.01
+0.64%
Apyx Medical Corp
BETR10.330.03
+0.29%
Better Home & Finance Holding Company

SQZB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SQZB has been loosely correlated with MDGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SQZB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
MDGL - SQZB
33%
Loosely correlated
+5.12%
ARRY - SQZB
33%
Loosely correlated
+5.43%
AXON - SQZB
33%
Poorly correlated
+2.60%
MIST - SQZB
31%
Poorly correlated
+4.96%
ACHL - SQZB
30%
Poorly correlated
+0.11%
More